Medtech company Indigo Diabetes has closed its €38m (US$44.8m) Series B funding to help develop its glucose monitoring sensor for people with diabetes. The funding round was led by Fund+,…
Medtech company Indigo Diabetes has closed its €38m (US$44.8m) Series B funding to help develop its glucose monitoring sensor for people with diabetes. The funding round was led by Fund+,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference